Stewart CJR, Fukunaga M. Struma Ovarii. In: WHO Classification of Tumours Editorial Board. Female genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2023 March 10]. (WHO classification of tumours series, 5th ed.; vol. 4). Available from: https://tumourclassification.iarc.who.int/chapters/34

Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008 Jun;19(2):135–8. https://doi.org/10.3802/jgo.2008.19.2.135. Epub 2008 Jun 20. PMID: 19471561; PMCID: PMC2676458.

Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 1993 Oct;12(4):333-43. https://doi.org/10.1097/00004347-199310000-00008. PMID: 8253550.

Article  CAS  PubMed  Google Scholar 

McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol. 2005 Feb;22(1):3-32. https://doi.org/10.1053/j.semdp.2005.11.002. PMID: 16512597.

Article  PubMed  Google Scholar 

Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, Bean S, Krigman HR, Roth LM, Young RH. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 2009 Sep;28(5):405-22. https://doi.org/10.1097/PGP.0b013e3181a27777. PMID: 19696610.

Article  PubMed  Google Scholar 

Jiang W, Lu X, Zhu ZL, Liu XS, Xu CJ. Struma ovarii associated with pseudo-Meigs’ syndrome and elevated serum CA 125: a case report and review of the literature. J Ovarian Res. 2010 Jul 29;3:18. https://doi.org/10.1186/1757-2215-3-18. PMID: 20670426; PMCID: PMC2923141.

Article  Google Scholar 

Wei S, Baloch ZW, LiVolsi VA. Pathology of Struma Ovarii: A Report of 96 Cases. Endocr Pathol. 2015 Dec;26(4):342–8. https://doi.org/10.1007/s12022-015-9396-1. PMID: 26374222.

Article  PubMed  Google Scholar 

Cui Y, Yao J, Wang S, Zhao J, Dong J, Liao L. The Clinical and Pathological Characteristics of Malignant Struma Ovarii: An Analysis of 144 Published Patients. Front Oncol. 2021 Mar 5;11:645156. https://doi.org/10.3389/fonc.2021.645156. PMID: 33763376.

Article  CAS  Google Scholar 

Leite I, Cunha TM, Figueiredo JP, Félix A. Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature. J Radiol Case Rep. 2013 Oct 1;7(10):24–33. https://doi.org/10.3941/jrcr.v7i10.1593. PMID: 24421920; PMCID: PMC3888341.

Logani S, Baloch ZW, Snyder PJ, Weinstein R, LiVolsi VA. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report. Thyroid. 2001 Nov;11(11):1073-5. https://doi.org/10.1089/105072501753271789. PMID: 11762718.

Article  CAS  PubMed  Google Scholar 

Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, et al. Malignant Struma Ovarii: An Analysis of 88 Cases, Including 27 With Extraovarian Spread. International Journal of Gynecological Pathology. 2009 Sep;28(5):405. https://doi.org/10.1097/PGP.0b013e3181a27777. PMID: 19696610.

Article  PubMed  Google Scholar 

Shaco-Levy R, Peng RY, Snyder MJ, Osmond GW, Veras E, Bean SM, et al. Malignant Struma Ovarii: A Blinded Study of 86 Cases Assessing Which Histologic Features Correlate With Aggressive Clinical Behavior. Archives of Pathology & Laboratory Medicine. 2012 Feb 1;136(2):172–8. https://doi.org/10.5858/arpa.2011-0092-OA. PMID: 22288964.

Article  Google Scholar 

Terayama N, Fujiwara S, Ueda S, Yamada T, Ohmichi M. Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report. J Med Case Rep. 2022 Sep 30;16(1):348. https://doi.org/10.1186/s13256-022-03590-6. PMID: 36176008; PMCID: PMC9524032.

Article  PubMed  PubMed Central  Google Scholar 

Li S, Kong S, Wang X, Zhang X, Yin M, Yang J. Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii. Front Med (Lausanne). 2021;8:774691. https://doi.org/10.3389/fmed.2021.774691. PMID: 35004743; PMCID: PMC8733601

Article  PubMed  PubMed Central  Google Scholar 

Li S, Yang T, Xiang Y, Li X, Zhang L, Deng S. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary. BMC Cancer. 2021 Apr 9;21(1):383. https://doi.org/10.1186/s12885-021-08118-7. PMID: 33836675.

Article  PubMed  PubMed Central  Google Scholar 

Rose PG, Arafah B, Abdul-Karim FW. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol. 1998 Sep;70(3):425–7. https://doi.org/10.1006/gyno.1998.5056. PMID: 9790800.

Article  CAS  PubMed  Google Scholar 

Matías-Guiu X, Forteza J, Prat J. Mixed strumal and mucinous carcinoid tumor of the ovary. Int J Gynecol Pathol. 1995 Apr;14(2):179–83. https://doi.org/10.1097/00004347-199504000-00013. PMID: 8601531.

Article  PubMed  Google Scholar 

Kim NR, Ha SY, Shin JW, Lim S, Park CY, Cho HY. Primary ovarian mixed strumal and mucinous carcinoid arising in an ovarian mature cystic teratoma. Journal of Obstetrics and Gynaecology Research. 2016;42(2):211–6. https://doi.org/10.1111/jog.12878. PMID: 26607856.

Article  PubMed  Google Scholar 

Quiñonez E, Schuldt M, Retamero JA, Nogales FF. Ovarian Strumal Carcinoid Containing Appendiceal-Type Mucinous Tumor Patterns Presenting as Pseudomyxoma Peritonei: International Journal of Gynecological Pathology. 2015 May;34(3):293–7. https://doi.org/10.1097/PGP.0000000000000138. PMID: 25760904.

Article  PubMed  Google Scholar 

Hamazaki S, Okino T, Tsukayama C, Okada S. Expression of thyroid transcription factor-1 in strumal carcinoid and struma ovarii: An immunohistochemical study. Pathology International. 2002;52(7):458–62. https://doi.org/10.1046/j.1440-1827.2002.01370.x. PMID: 12167104.

Article  CAS  PubMed  Google Scholar 

Zhang X, Jones A, Jenkins SM, Huang Y. Ki67 Proliferative Index in Carcinoid Tumors Involving Ovary. Endocr Pathol. 2018 Mar 1;29(1):43–8. https://doi.org/10.1007/s12022-017-9510-7. PMID: 29349725.

Article  CAS  PubMed  Google Scholar 

Theurer S, Ingenwerth M, Herold T, Herrmann K, Schmid KW. Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal Carcinoids. Endocr Pathol. 2020 Jun 1;31(2):101–7. https://doi.org/10.1007/s12022-020-09608-3. PMID: 32124226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dayal Y, Tashjian Jr. AH, Wolfe HJ. Immunocytochemical localization of calcitonin-producing cells in a strumal carcinoid with amyloid stroma. Cancer. 1979;43(4):1331–8. https://doi.org/10.1002/1097-0142(197904)43:4<1331::AID-CNCR2820430423>3.0.CO;2-4. PMID: 376090.

Robboy SJ, Scully RE. Strumal carcinoid of the ovary: An analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer. 1980;46(9):2019–34. https://doi.org/10.1002/1097-0142(19801101)46:9<2019::AID-CNCR2820460921>3.0.CO;2-W. PMID: 7427909.

Muller KE, Tafe LJ, Gonzalez JL, West LA, Schned AR. Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol. 2015 Jan;34(1):30–5. https://doi.org/10.1097/PGP.0000000000000117. PMID: 25473750.

Article  PubMed  Google Scholar 

Rutgers JL, Scully RE. Functioning ovarian tumors with peripheral steroid cell proliferation: a report of twenty-four cases. Int J Gynecol Pathol. 1986;5(4):319–37. https://doi.org/10.1097/00004347-198612000-00004. PMID: 3804558.

Article  CAS  PubMed  Google Scholar 

Ashton MA. Strumal carcinoid of the ovary associated with hyperinsulinaemic hypoglycaemia and cutaneous melanosis. Histopathology. 1995;27(5):463–7. https://doi.org/10.1111/j.1365-2559.1995.tb00311.x. PMID: 8575738.

Article  CAS  PubMed  Google Scholar 

Zhang PJ, Gao HG, Pasha TL, Litzky L, Livolsi VA. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2009 Jan;28(1):10-8. https://doi.org/10.1097/PGP.0b013e3181804bc6. PMID: 19047914.

Article  PubMed  Google Scholar 

Li S, Wang X, Sui X, Zhang X, Yin M, Yang J. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid. BMC Cancer. 2022 Oct 24;22(1):1090.

Article  PubMed  PubMed Central  Google Scholar 

Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res. 2000 Sep;19(3):271–80.

CAS  PubMed  Google Scholar 

Roth LM, Karseladze AI. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol. 2008 Apr;27(2):213-22. https://doi.org/10.1097/PGP.0b013e318158e958. PMID: 18317221.

Article  PubMed  Google Scholar 

Asaturova A, Magnaeva A, Tregubova A, Kometova V, Karamurzin Y, Martynov S, Lipatenkova Y, Adamyan L, Palicelli A. Malignant Clinical Course of “Proliferative” Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls. Diagnostics (Basel). 2022 Jun 7;12(6):1411. https://doi.org/10.3390/diagnostics12061411. PMID: 35741221; PMCID: PMC9222151.

Article  PubMed  PubMed Central  Google Scholar 

Niu HL, Pasha TL, Pawel BR, LiVolsi VA, Zhang PJ. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance. Int J Gynecol Pathol. 2009 Jul;28(4):301-7. https://doi.org/10.1097/PGP.0b013e31819901c6. PMID: 19483637.

Article  PubMed  Google Scholar 

Ordóñez NG. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):429-44. https://doi.org/10.1097/PAI.0b013e31825439bc. PMID: 22531688.

Article  CAS  PubMed  Google Scholar